ViGeneron Competitors and Similar CompaniesClear all
ViGeneron's competitors and similar companies include apceth Biopharma, Spirovant Sciences, Angionetics and ToolGen.
 ViGeneron ViGeneron is a gene therapy company dedicated to developing innovative gene therapies based on AAV capsids and AAV vectors. |  apceth Biopharma apceth Biopharma is a contract development and manufacturing organization focused on cell and gene therapy. |  Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. |  Angionetics Angionetics is a company focused on the late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. | ||
Founding Date | Founding Date 2017 | Founding Date 2007 | Founding Date 2016 | Founding Date N/A | Founding Date 1999 |
Type | Type Private | Type Subsidiary | Type Private | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Starnberg, DE HQ Planegg, DE | Locations Ottobrunn, DE HQ München, DE | Locations Philadelphia, US HQ | Locations San Diego, US HQ | Locations KR HQ |
Employees | Employees 4 | Employees 234% decrease | Employees 234% decrease | Employees N/A | Employees 5 |
For sources of this data, please see the company profile
View Company Profiles
apceth Biopharma
HQ
Ottobrunn, DE
apceth Biopharma is a contract development and manufacturing organization focused on cell and gene therapy.
View companySpirovant Sciences
HQ
Philadelphia, US
Employees
23↓ 4% decrease
Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
View companyAngionetics
HQ
San Diego, US
Angionetics is a company focused on the late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease.
View company